Overview

The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.

Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
Anidulafungin may be effective for the treatment of invasive Candida infections. The purpose of the study is to find the balance between dose tolerance and effectiveness of several doses for the treatment of United States patients with invasive candidiasis.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Collaborator:
Vicuron Pharmaceuticals
Treatments:
Anidulafungin
Echinocandins